Diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance - Body's cells become less responsive to insulin, leading to decreased glucose uptake and increased blood glucose levels, a hallmark of Type 2 Diabetes.

• Secondary mechanism: Insulin deficiency - In Type 1 Diabetes, autoimmune destruction of pancreatic beta cells results in little to no insulin production, causing elevated blood glucose.

• Key complication: Hyperglycemia-related damage - Chronic high blood glucose leads to damage of blood vessels and nerves, resulting in complications such as neuropathy, retinopathy, and nephropathy.

Patient Profile

Demographics:

56-year-old male, office administrator

History:

• Type 2 Diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Metformin, Lisinopril, Atorvastatin

• No known drug allergies

Current Presentation:

• Chief complaint: Increasing fatigue and occasional blurred vision

• Key symptoms: Numbness in feet, frequent urination, excessive thirst

• Vital signs: Blood pressure 148/92 mmHg, heart rate 88 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, blood glucose level 220 mg/dL

Section 1

During the initial assessment, the nurse notes that the patient's skin appears dry and his mucous membranes are slightly tacky, suggesting mild dehydration, likely secondary to osmotic diuresis from uncontrolled blood glucose levels. The patient's gait is also slightly unsteady, which he attributes to the numbness in his feet, a symptom consistent with peripheral neuropathy. On further examination, the nurse observes diminished sensation to light touch and vibration in the patient's lower extremities, reinforcing the suspicion of diabetic neuropathy. Additionally, there is evidence of early retinopathy upon fundoscopic examination, as indicated by microaneurysms and small hemorrhages in the retina.

A recent panel of diagnostic tests reveals an elevated Hemoglobin A1c of 9.0%, indicating poor long-term glucose control. The patient's lipid profile shows elevated LDL cholesterol levels at 160 mg/dL, despite being on atorvastatin, suggesting suboptimal management of hyperlipidemia. Renal function tests demonstrate a slightly elevated creatinine level of 1.4 mg/dL and a microalbuminuria of 45 mg/L, suggesting early diabetic nephropathy. These findings highlight the impact of chronic hyperglycemia and poor disease management on multiple organ systems, necessitating a more comprehensive and aggressive approach to treatment.

In light of these findings, the healthcare team decides to adjust the patient's treatment plan. The decision is made to introduce insulin therapy to better control blood glucose levels and to intensify lifestyle interventions, including dietary modifications and a structured exercise regimen, to address metabolic risk factors. Additionally, a referral to a podiatrist for regular foot assessments and to an ophthalmologist for eye monitoring is arranged. The nurse educates the patient on the importance of adhering to prescribed therapies and routinely monitoring blood glucose levels to prevent further complications. This comprehensive approach aims to halt the progression of diabetic complications and improve the patient's quality of life.

Section 2

Two months after initiating the revised treatment plan, the patient returns for a follow-up appointment. During the assessment, the nurse observes an improvement in the patient's hydration status; his skin is less dry, and mucous membranes are moist. However, the patient reports occasional episodes of dizziness, particularly when rising from a seated position, suggesting possible orthostatic hypotension. Vital signs reveal a blood pressure of 110/70 mmHg when seated, dropping to 90/60 mmHg upon standing, confirming the suspicion. This change in status prompts the healthcare team to explore potential causes, including the recent introduction of insulin therapy that may have resulted in tighter glucose control but also increased the risk of hypoglycemia.

The nurse conducts a thorough foot examination, noting that the patient's peripheral neuropathy symptoms persist, with no significant changes in sensation. A new finding, however, is the presence of a small area of skin breakdown on the plantar aspect of the left foot, likely secondary to pressure and unnoticed due to diminished sensation. This ulceration, though superficial, raises concerns about the potential for infection and delayed healing, common complications in diabetic patients. The nurse emphasizes the importance of daily foot care and proper footwear to the patient, reinforcing education on early signs of infection and the need for prompt medical attention.

A recent lab panel shows a slight improvement in the patient's Hemoglobin A1c, now at 8.2%, indicating better glycemic control but still above the target range. Lipid levels show some improvement with LDL cholesterol reduced to 140 mg/dL, yet further adjustments to lipid-lowering therapy may be necessary. Renal function tests reveal stable creatinine levels, but persistent microalbuminuria at 40 mg/L suggests ongoing renal compromise. In light of these findings, the healthcare team considers optimizing antihypertensive therapy, possibly introducing an ACE inhibitor to address both blood pressure and renal protection. This nuanced approach underscores the need for ongoing monitoring and adjustment of the patient's management plan to mitigate the risk of further complications.

Section 3

Two weeks later, the patient returns to the clinic reporting increased fatigue and swelling in his lower extremities. The nurse notes mild bilateral pitting edema in the ankles and a slight increase in body weight since the last visit, likely indicating fluid retention. Upon reviewing the patient's recent dietary habits, it becomes apparent that he has been consuming more processed foods, potentially leading to increased sodium intake. Vital signs reveal a blood pressure of 130/80 mmHg while seated, suggesting a need for reevaluation of his antihypertensive regimen. The nurse suspects that the edema and fatigue may be related to both dietary choices and suboptimal blood pressure management.

A repeat lab panel is ordered, which shows a further reduction in LDL cholesterol to 130 mg/dL, indicating some positive response to dietary changes and medication. However, the microalbuminuria has increased to 50 mg/L, signaling a potential progression in renal compromise. Serum electrolyte levels are within normal ranges, but a mild increase in serum creatinine from 1.0 to 1.2 mg/dL suggests a slight deterioration in renal function. Given these findings, the healthcare team considers adjusting the patient's antihypertensive therapy, possibly by increasing the dose of the ACE inhibitor to not only better control blood pressure but also to provide enhanced renal protection.

The patient's ongoing challenges underscore the complexity of managing diabetes with multiple comorbidities. The healthcare team emphasizes the importance of dietary modifications, particularly reducing sodium intake, and the need for consistent medication adherence. The nurse collaborates with a dietitian to develop a more tailored nutrition plan that aligns with the patient's cultural preferences and lifestyle, aiming to improve overall cardiovascular and renal outcomes. This comprehensive approach reflects the necessity of addressing multiple facets of the patient's condition to prevent further complications and promote optimal health.

Section 4

Two weeks after the dietary consultation and adjustment to his antihypertensive medication, the patient returns to the clinic for a follow-up evaluation. During the initial assessment, the nurse notes that the patient appears more alert and reports feeling less fatigued, which suggests a positive response to the interventions. However, the patient still experiences intermittent swelling in his ankles, particularly at the end of the day. Further examination reveals persistent mild bilateral pitting edema. The patient's weight has stabilized, indicating that fluid retention may be controlled, albeit not completely resolved.

Vital signs are reassessed, demonstrating a slight improvement in blood pressure, now measuring 125/78 mmHg, which suggests that the increased dose of the ACE inhibitor is effectively managing his hypertension. The nurse inquires about the patient's adherence to the dietary recommendations and antihypertensive regimen, and the patient confirms that he has been diligent in following the new plan. The nurse reinforces the importance of maintaining these lifestyle changes and medication adherence to continue improving his cardiovascular and renal health.

A new set of labs is ordered to monitor any further changes in renal function and overall metabolic control. Results show that microalbuminuria has stabilized at 50 mg/L, and serum creatinine remains at 1.2 mg/dL, indicating no further renal decline. The patient's HbA1c has decreased slightly to 7.3%, suggesting better glycemic control. The healthcare team concludes that while the patient's condition is improving, ongoing monitoring and adjustments will be necessary to prevent future complications. They continue to emphasize the significance of a multidisciplinary approach, including regular consultations with the dietitian and primary care provider, to address the complexities of his diabetes management.

Section 5

Two months later, the patient returns to the clinic for a routine follow-up. During the initial assessment, the nurse observes that the patient has gained 3 kg (approximately 6.6 lbs) since his last visit. He reports feeling more fatigued lately and experiencing occasional shortness of breath during light activity, such as walking up a flight of stairs. The nurse also notes that the bilateral pitting edema in his ankles has worsened, now extending to the mid-calf level. These findings prompt a thorough review of his current medications and adherence to the prescribed dietary plan.

Vital signs are recorded, revealing a blood pressure of 132/85 mmHg, slightly higher than the previous measurement. Although still within an acceptable range, the increase raises concerns about the possibility of fluid overload or the development of heart failure. To further investigate, the healthcare provider orders additional laboratory tests, including a complete blood count (CBC), serum electrolytes, and B-type natriuretic peptide (BNP) to assess cardiac function. The patient’s HbA1c is now at 7.5%, indicating a slight deterioration in his glycemic control, possibly due to the recent weight gain and fluid retention.

The lab results show an elevated BNP level of 250 pg/mL, suggesting a potential compromise in cardiac function, while electrolytes reveal hyponatremia with a sodium level of 132 mmol/L. These findings, combined with the clinical observations, indicate the development of early-stage heart failure as a complication of his diabetes and hypertension. The healthcare team decides to adjust his pharmacotherapy, incorporating a diuretic to manage fluid overload and considering the need for further cardiac evaluation. This change in the patient's condition emphasizes the importance of continuous multidisciplinary management and close monitoring to prevent the escalation of complications and maintain overall health stability.